133 related articles for article (PubMed ID: 29101390)
1. L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.
Alsaran H; Elkhadragy L; Shakya A; Long W
Sci Rep; 2017 Nov; 7(1):14979. PubMed ID: 29101390
[TBL] [Abstract][Full Text] [Related]
2. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
Elkhadragy L; Alsaran H; Morel M; Long W
J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
[TBL] [Abstract][Full Text] [Related]
3. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
[TBL] [Abstract][Full Text] [Related]
4. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
Elkhadragy L; Alsaran H; Long W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
[TBL] [Abstract][Full Text] [Related]
5. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
[TBL] [Abstract][Full Text] [Related]
6. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.
Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM
Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708
[TBL] [Abstract][Full Text] [Related]
7. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
Elkhadragy L; Chen M; Miller K; Yang MH; Long W
Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
[TBL] [Abstract][Full Text] [Related]
8. Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.
Aberg E; Torgersen KM; Johansen B; Keyse SM; Perander M; Seternes OM
J Biol Chem; 2009 Jul; 284(29):19392-401. PubMed ID: 19473979
[TBL] [Abstract][Full Text] [Related]
9. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
Chen M; Myers AK; Markey MP; Long W
J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
[TBL] [Abstract][Full Text] [Related]
10. Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression.
Julien C; Coulombe P; Meloche S
J Biol Chem; 2003 Oct; 278(43):42615-24. PubMed ID: 12915405
[TBL] [Abstract][Full Text] [Related]
11. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
[TBL] [Abstract][Full Text] [Related]
12. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.
Perander M; Al-Mahdi R; Jensen TC; Nunn JA; Kildalsen H; Johansen B; Gabrielsen M; Keyse SM; Seternes OM
Sci Rep; 2017 Mar; 7():43471. PubMed ID: 28252035
[TBL] [Abstract][Full Text] [Related]
13. Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.
De la Mota-Peynado A; Chernoff J; Beeser A
J Biol Chem; 2011 Apr; 286(15):13603-11. PubMed ID: 21317288
[TBL] [Abstract][Full Text] [Related]
14. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
15. Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.
Déléris P; Rousseau J; Coulombe P; Rodier G; Tanguay PL; Meloche S
J Cell Physiol; 2008 Dec; 217(3):778-88. PubMed ID: 18720373
[TBL] [Abstract][Full Text] [Related]
16. Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.
Ronkina N; Schuster-Gossler K; Hansmann F; Kunze-Schumacher H; Sandrock I; Yakovleva T; Lafera J; Baumgärtner W; Krueger A; Prinz I; Gossler A; Kotlyarov A; Gaestel M
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642948
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for mitogen-activated protein kinase localization.
Bind E; Kleyner Y; Skowronska-Krawczyk D; Bien E; Dynlacht BD; Sánchez I
Mol Biol Cell; 2004 Oct; 15(10):4457-66. PubMed ID: 15269285
[TBL] [Abstract][Full Text] [Related]
18. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3.
Hansen CA; Bartek J; Jensen S
Cell Cycle; 2008 Feb; 7(3):325-34. PubMed ID: 18235225
[TBL] [Abstract][Full Text] [Related]
19. Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.
Elkhadragy L; Myers A; Long W
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611058
[TBL] [Abstract][Full Text] [Related]
20. ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression.
Wang W; Bian K; Vallabhaneni S; Zhang B; Wu RC; O'Malley BW; Long W
J Cell Physiol; 2014 Oct; 229(10):1529-37. PubMed ID: 24585635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
